Transglutaminase 2 nuclear localization enhances glioblastoma radiation resistance

Radiotherapy remains the cornerstone of treatment for glioblastoma (GBM). However, the frequent occurrence of radiation resistance presents a significant therapeutic challenge. A comprehensive understanding of the mechanisms underlying this resistance is essential for improving GBM treatment strateg...

Full description

Saved in:
Bibliographic Details
Published inDiscover. Oncology Vol. 16; no. 1; pp. 952 - 13
Main Authors Sun, Cuiping, Du, Zhiyong, Yang, Wenhui, Wang, Qing
Format Journal Article
LanguageEnglish
Published New York Springer US 30.05.2025
Springer Nature B.V
Springer
Subjects
Antibodies
Biotechnology industry
Brain cancer
Cancer Research
Cell cycle
Chemotherapy
DNA damage
DNA damage repair
Enzymes
Flow cytometry
Glioblastoma
Glioma
Internal Medicine
Localization
Medical prognosis
Medicine
Medicine & Public Health
Microscopy
Molecular Medicine
Oncology
p53
Proteins
Radiation
Radiation resistance
Radiotherapy
Surgical Oncology
Transglutaminase 2
Translocation
United States > US
China
Shanghai China
Translocation
DNA damage repair
Radiation resistance
Transglutaminase 2
Glioblastoma
p53
Online AccessGet full text

Cover

More Information
Summary:Radiotherapy remains the cornerstone of treatment for glioblastoma (GBM). However, the frequent occurrence of radiation resistance presents a significant therapeutic challenge. A comprehensive understanding of the mechanisms underlying this resistance is essential for improving GBM treatment strategies. In the present study, live-dead cell staining and immunofluorescence staining were employed, and irradiation-resistant cell lines were established. It was observed that transglutaminase 2 (TGM2) plays a pivotal role in enhancing radiation resistance in GBM, facilitating cell proliferation, and promoting DNA damage repair following irradiation. Moreover, immunofluorescence and nucleoplasmic protein extraction assays revealed that TGM2 in GBM rapidly translocates into the nucleus upon irradiation. Through co-immunoprecipitation assays, TGM2 was identified as binding to an increased amount of p53 proteins, thereby promoting p53 degradation post-irradiation. Notably, inhibition of this interaction resulted in a reduction of radiation resistance in GBM. In summary, this study underscores the significance of TGM2 nuclear translocation in radiation resistance and suggests that disrupting TGM2 binding to p53 may offer novel therapeutic insights for overcoming radiation resistance in GBM.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:2730-6011
2730-6011
DOI:10.1007/s12672-025-02599-9